HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morgane Le Bras Selected Research

Heterogeneous-Nuclear Ribonucleoprotein Group F-H

3/2022Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of Glioblastoma.
5/2021Author Correction: hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma.
1/2020hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Morgane Le Bras Research Topics

Disease

7Neoplasms (Cancer)
03/2022 - 01/2006
4Acute Promyelocytic Leukemia
11/2017 - 07/2010
4Leukemia
11/2017 - 07/2010
3Glioblastoma (Glioblastoma Multiforme)
03/2022 - 01/2020
2Genomic Instability
05/2021 - 01/2020
2Breast Neoplasms (Breast Cancer)
01/2020 - 03/2016
1Brain Neoplasms (Brain Tumor)
03/2022
1COVID-19
03/2021
1Infections
03/2021
1Pneumonia (Pneumonitis)
03/2021
1Frailty
05/2013
1Genetic Translocation (Chromosomal Translocation)
07/2012
1Acute Disease
07/2012
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2011
1Lung Neoplasms (Lung Cancer)
09/2006
1Adenoma (Adenomas)
09/2006
1Glioma (Gliomas)
09/2006
1Sarcoma (Soft Tissue Sarcoma)
06/2006
1Carcinogenesis
06/2006

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
03/2021 - 07/2012
3Heterogeneous-Nuclear Ribonucleoprotein Group F-HIBA
03/2022 - 01/2020
2RNA-Binding Proteins (RNA-Binding Protein)IBA
03/2022 - 03/2016
2RNA (Ribonucleic Acid)IBA
05/2021 - 01/2020
2ArsenicIBA
11/2017 - 07/2012
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2014 - 07/2012
2lonidamineIBA
05/2010 - 09/2006
1XAV-19IBA
03/2021
1Neutralizing AntibodiesIBA
03/2021
1Transcription Factors (Transcription Factor)IBA
01/2020
1Heterogeneous Nuclear Ribonucleoprotein A1IBA
03/2016
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
03/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2016
1Messenger RNA (mRNA)IBA
03/2016
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2012
1Bax protein (53-86)IBA
06/2011
1Superoxides (Superoxide)IBA
06/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2011
1Aligeron (AS 2)IBA
07/2010
1Oncogene Proteins (Oncogene Protein)IBA
07/2010
1Oxidants (Oxidizing Agents)IBA
07/2010
1Adenine NucleotidesIBA
05/2010
1Protein Isoforms (Isoforms)IBA
05/2010
1StaurosporineIBA
05/2010
1Matrix Metalloproteinases (MMPs)IBA
09/2006
1Hormones (Hormone)IBA
09/2006
1Codon (Codons)IBA
06/2006
1HexokinaseIBA
01/2006
1NF-kappa B (NF-kB)IBA
01/2006
1Protein Kinases (Protein Kinase)IBA
01/2006

Therapy/Procedure

3Therapeutics
03/2022 - 01/2020
1Immunotherapy
03/2021
1Radiotherapy
06/2006